RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
1.045
-0.025 (-2.34%)
Nov 21, 2024, 10:56 AM EST - Market open
RAPT Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | 1.53 | 3.81 | 5.04 | - | |
| Revenue Growth (YoY) | - | - | -59.95% | -24.38% | - | - | |
| Gross Profit | - | - | 1.53 | 3.81 | 5.04 | - | |
| Selling, General & Admin | 27.33 | 26.06 | 20.24 | 16.04 | 12.77 | 8.72 | |
| Research & Development | 87.53 | 101 | 67.08 | 56.99 | 45.49 | 34.91 | |
| Operating Expenses | 114.85 | 127.06 | 87.32 | 73.02 | 58.26 | 43.63 | |
| Operating Income | -114.85 | -127.06 | -85.8 | -69.21 | -53.21 | -43.63 | |
| Other Non Operating Income (Expenses) | 3.85 | 4.53 | 1.66 | 1.28 | 1.81 | 1.29 | |
| EBT Excluding Unusual Items | -111 | -122.53 | -84.13 | -67.93 | -51.41 | -42.34 | |
| Gain (Loss) on Sale of Investments | 3.51 | 5.74 | 0.3 | -1.27 | -0.5 | - | |
| Pretax Income | -107.49 | -116.8 | -83.84 | -69.2 | -51.9 | -42.34 | |
| Income Tax Expense | - | - | - | - | 0.99 | 0.66 | |
| Net Income | -107.49 | -116.8 | -83.84 | -69.2 | -52.89 | -43 | |
| Net Income to Common | -107.49 | -116.8 | -83.84 | -69.2 | -52.89 | -43 | |
| Shares Outstanding (Basic) | 39 | 38 | 33 | 27 | 24 | 4 | |
| Shares Outstanding (Diluted) | 39 | 38 | 33 | 27 | 24 | 4 | |
| Shares Change (YoY) | 2.72% | 17.82% | 18.80% | 13.49% | 455.27% | 598.45% | |
| EPS (Basic) | -2.78 | -3.05 | -2.58 | -2.53 | -2.19 | -9.89 | |
| EPS (Diluted) | -2.78 | -3.05 | -2.58 | -2.53 | -2.19 | -9.89 | |
| Free Cash Flow | -100.8 | -98.17 | -71.62 | -61.78 | -40.89 | -36.36 | |
| Free Cash Flow Per Share | -2.60 | -2.56 | -2.20 | -2.26 | -1.69 | -8.37 | |
| Gross Margin | - | - | 100.00% | 100.00% | 100.00% | - | |
| Operating Margin | - | - | -5618.53% | -1815.08% | -1055.41% | - | |
| Profit Margin | - | - | -5490.37% | -1814.95% | -1049.03% | - | |
| Free Cash Flow Margin | - | - | -4689.98% | -1620.27% | -810.97% | - | |
| EBITDA | -113.61 | -125.85 | -84.75 | -68.21 | -52.09 | -42.3 | |
| D&A For EBITDA | 1.24 | 1.22 | 1.05 | 1 | 1.12 | 1.33 | |
| EBIT | -114.85 | -127.06 | -85.8 | -69.21 | -53.21 | -43.63 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.